These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2970143)

  • 21. Effect of brequinar sodium on accelerated cardiac allograft rejection in presensitized recipients.
    Nozaki S; Ito T; Kamiike W; Uchikoshi F; Yamamoto S; Nakata S; Shirakura R; Miyata M; Matsuda H; Stepkowski SM
    Transplant Proc; 1994 Aug; 26(4):2333-5. PubMed ID: 7520633
    [No Abstract]   [Full Text] [Related]  

  • 22. Phenotypic and functional analysis of kidney infiltrating T cells escaping monoclonal antibody treatment in primate renal transplantation.
    Nocera A; Cosimi AB; Colvin RB; Gesner ML; Fuller TC
    Transplant Proc; 1988 Apr; 20(2):205-6. PubMed ID: 3129830
    [No Abstract]   [Full Text] [Related]  

  • 23. Renal transplantation between histocompatible donor-recipient pairs.
    Seigler HF; Stickel DL; Gunnells JC; McCoy R; Ward FE; Anderson EE; Amos DB
    Transplant Proc; 1972 Dec; 4(4):439-46. PubMed ID: 4264867
    [No Abstract]   [Full Text] [Related]  

  • 24. Relevance of mixed lymphocyte reactions to renal allograft rejection mechanisms.
    Lindquist RR; Guttmann RD
    Transplant Proc; 1971 Mar; 3(1):879-82. PubMed ID: 4937985
    [No Abstract]   [Full Text] [Related]  

  • 25. Cytotoxicity and IL 2 reactivity of cells from rejected or nonrejected allografts.
    Dallman MJ; Wood KJ; Morris PJ
    Transplant Proc; 1988 Apr; 20(2):226-8. PubMed ID: 3129832
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of cell-mediated lympholysis and mixed lymphocyte culture in the immunologic evaluation for renal transplantation.
    Harmon WE; Parkman R; Lavin PT; Grupe WE; Ingelfinger JR; Yunis EJ; Levey RH
    J Immunol; 1982 Oct; 129(4):1573-7. PubMed ID: 6213715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations in human regulatory T lymphocytes subpopulations after renal allografting.
    Ellis TM; Lee HM; Mohanakumar T
    J Immunol; 1981 Dec; 127(6):2199-203. PubMed ID: 6457868
    [No Abstract]   [Full Text] [Related]  

  • 28. Analysis of the mechanism of allograft rejection and cell-mediated immunity. I. Accelerated rejection of tumour allografts without augmented cytotoxicity in the spleen cells.
    Nanishi F; Nomoto K; Taniguchi K; Kubo C
    Immunology; 1980 May; 40(1):67-76. PubMed ID: 7419243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship of the histocompatibility locus in the pig to allograft survival.
    White DJ; Bradley B; Calne RY; Binns RM
    Transplant Proc; 1973 Mar; 5(1):317-20. PubMed ID: 4266654
    [No Abstract]   [Full Text] [Related]  

  • 30. Suppression of allograft rejection in the rat by pretreatment with cells of the T-helper, but not T-cytotoxic suppressor phenotype.
    Cranston D; Wood KJ; Carter NP; Morris PJ
    Transplant Proc; 1987 Feb; 19(1 Pt 1):505. PubMed ID: 2978918
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of antiglobulin microcytotoxicity test and mixed leukocyte culture to evaluate prognosis in renal transplant recipients.
    Farrow SS; Rossen RD; Suki WN; Hersh EM
    Proc Clin Dial Transplant Forum; 1973; 3():74-6. PubMed ID: 4283133
    [No Abstract]   [Full Text] [Related]  

  • 32. Isotretinoin ameliorates renal damage in experimental acute renal allograft rejection.
    Kiss E; Adams J; Gröne HJ; Wagner J
    Transplantation; 2003 Aug; 76(3):480-9. PubMed ID: 12923432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pretreatment with portal venous ultraviolet B-irradiated donor alloantigen promotes donor-specific tolerance to rat nerve allografts.
    Genden EM; Mackinnon SE; Yu S; Hunter DA; Flye MW
    Laryngoscope; 2001 Mar; 111(3):439-47. PubMed ID: 11224773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The mechanism of suppression of renal allograft rejection in rats by donor strain blood.
    Morris PJ; Fabre JW
    Surg Forum; 1972; 23(0):265-7. PubMed ID: 4601082
    [No Abstract]   [Full Text] [Related]  

  • 35. Regulation of T-cell-mediated cytotoxic allograft response in human transplant recipients.
    Thomas J; Thomas F; Edwards E; Hoffman S; Lee HM
    Transplant Proc; 1981 Sep; 13(3):1594-8. PubMed ID: 6458130
    [No Abstract]   [Full Text] [Related]  

  • 36. Reduction of Foxp3-expressing regulatory T cell infiltrates during the progression of renal allograft rejection in a mouse model.
    Wang S; Jiang J; Guan Q; Lan Z; Wang H; Nguan CY; Jevnikar AM; Du C
    Transpl Immunol; 2008 May; 19(2):93-102. PubMed ID: 18503884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two-color flow cytometry and functional analysis of lymphocytes cultured from human renal allografts: identification of a Leu-2+3+ subpopulation.
    Preffer FI; Colvin RB; Leary CP; Boyle LA; Tuazon TV; Lazarovits AI; Cosimi AB; Kurnick JT
    J Immunol; 1986 Nov; 137(9):2823-30. PubMed ID: 3093583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between the allogeneic proliferative response and the outcome of renal transplantation.
    Pouteil-Noble C; Betuel H; Freidel AC; Dubernard JM; Touraine JL
    Transplant Proc; 1987 Oct; 19(5):3637-9. PubMed ID: 2960042
    [No Abstract]   [Full Text] [Related]  

  • 39. The correlation between humoral antibodies and rejection after renal transplantation.
    Yoshioka H; McCalmon RT
    Jpn J Surg; 1979 Jun; 9(2):95-101. PubMed ID: 156277
    [No Abstract]   [Full Text] [Related]  

  • 40. Human renal allograft-derived T cell lines.
    McKenna R; Rush DN; Jeffery JR
    Transplant Proc; 1987 Aug; 19(4):3391-3. PubMed ID: 2956739
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.